A Delphi Survey for Key Stakeholders to Identify Priority Self-management Outcomes for Chronic Kidney Disease
Taking an Active Role in Your Own Healthcare: A Delphi Survey for Key Stakeholders to Identify Priority Self-management Outcomes for Chronic Kidney Disease (SM-CKD Delphi Study)
1 other identifier
observational
140
1 country
1
Brief Summary
The purpose of this Delphi study is to identify priority outcomes for self-management in earlier (non-dialysis) stages of CKD from the perspectives of different stakeholder groups in the UK. The findings of this study will be used to inform outcome measure selection for research and clinical evaluations of self-management resources and to support implementation, commissioning and uptake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 3, 2023
CompletedFirst Submitted
Initial submission to the registry
August 7, 2023
CompletedFirst Posted
Study publicly available on registry
August 15, 2023
CompletedResults Posted
Study results publicly available
April 30, 2026
CompletedApril 30, 2026
January 1, 2026
11 months
August 7, 2023
October 21, 2024
April 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Open Ended Free Text Question (Identifying Stakeholder Views on the 3 Most Important Outcomes for Self-management)
Round 1- Participants are asked to describe the 3 most important outcomes for self-management in people with non-dialysis CKD from their own perspective or opinion
Between 3 to 6 month
Consensus Rating (Rating Each Item for Importance)
Round 2- Participants are asked to rate each item on a 9 point Likert-type scale, ranging from 1 (not important) to 9 (critically important). Higher scores indicate greater perceived importance of the item. Items were analysed individually; no total or subscale scores were calculated. For each item, the distribution of ratings and mean score were computed. Consensus was predefined as at least 70% of participants rating an item between 7 and 9 (critical importance), or a mean score of ≥7. Items not meeting this threshold were removed in subsequent Delphi rounds.
Between 3 to 6 month
Consensus Ranking (Ranking Items to Identify Top 3 Items)
Round 3- Participants are asked to rank each item and themes in order from high to low importance to identify the most valued outcomes
Between 3 to 6 month
Study Arms (2)
Cohort 1: Professional Expert
This includes Healthcare professionals (HCPs) who look after people with CKD in the UK, anyone involved in designing, developing, managing and commissioning of CKD healthcare in the UK and researchers interested in self-management or CKD
Cohort 2: Non-Professional Expert
This stakeholder group comprised individuals living with chronic kidney disease (CKD) and informal caregivers (e.g., family members or significant others). Caregivers were not analyzed as a separate study arm due to the small number enrolled and overlap in roles, as some participants with CKD also identified as caregivers. For analytic purposes, responses were therefore combined into a single pre-specified stakeholder category representing lay or non-professional expertise. This combined reporting approach reflects established methodology in CKD Delphi studies, including those conducted by the Standardised Outcomes in Nephrology (SONG) initiative. This grouping does not represent an additional intervention or control arm, but rather a stakeholder classification used solely for descriptive and consensus analyses.
Interventions
Multiple survey rounds identifying most important outcomes for effective self-management for non-dialysis CKD
Eligibility Criteria
1. People living with CKD. This survey focusses on people with non-dialysis CKD, typically stages 3-4. However, we will not exclude participation by those at a more advanced stage or receiving renal replacement therapy (dialysis or transplant) as these people also have lived experience of earlier stages to draw on. 2. Carers and Supporters of people with CKD (expected to be a significant other i.e. spouse or partner, close family member or friend that are involved in the regular care and support to a person living with CKD) 3. Healthcare professionals (HCPs) who look after people with CKD in the UK 4. Anyone involved in designing, developing, managing and commissioning of CKD healthcare in the UK 5. Researchers interested in self-management or CKD
You may qualify if:
- People with diagnosis of CKD in the UK
- Their close family and friend
- Healthcare professionals who look after people with CKD in the UK
- Anyone involved in designing, developing, managing and commissioning CKD healthcare services in the UK
- Researchers related in a topic related to self-management or CKD
You may not qualify if:
- Any participant residing outside of the UK
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Leicester
Leicester, LE1 7RH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Naeema Patel
- Organization
- University of Leicester
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 7, 2023
First Posted
August 15, 2023
Study Start
May 5, 2022
Primary Completion
April 3, 2023
Study Completion
April 3, 2023
Last Updated
April 30, 2026
Results First Posted
April 30, 2026
Record last verified: 2026-01